ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,347Medicare Part D Prescriptions Filled, Including Refills

Rank: 482 out of 4623

$298K Total Retail Price of All Prescriptions

Rank: 1636 out of 4623

338 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

20% of this provider’s 338 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 7,173 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$29 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
OMEPRAZOLE 373 272 1 7
METFORMIN HCL 369 283 2 6
CIPROFLOXACIN HCL 346 224 3 43
LISINOPRIL 328 238 4 4
SIMVASTATIN 321 226 5 2
ACETAMINOPHEN-CODEINE 276 188 S3 6 144
AMLODIPINE BESYLATE 273 200 7 5
LEVOTHYROXINE SODIUM 254 162 8 1
FUROSEMIDE 241 160 9 8
TIZANIDINE HCL 224 166 10 111
METOPROLOL TARTRATE 209 187 11 9
LOVASTATIN 191 173 12 34
SULINDAC 190 141 13 318
HYDROCHLOROTHIAZIDE 190 160 13 10
TRAMADOL HCL 169 109 15 15
PREDNISONE 169 117 15 50
HYDROCODONE-ACETAMINOPHEN 158 98 S3 17 3
ZOLPIDEM TARTRATE 151 94 18 18
GABAPENTIN 146 88 19 16
CLEMASTINE FUMARATE 141 89 R 20 344
SERTRALINE HCL 134 76 21 26
DOXYCYCLINE HYCLATE 134 80 21 101
GEMFIBROZIL 125 98 23 94
AMOXICILLIN 120 90 24 95
LISINOPRIL-HYDROCHLOROTHIAZIDE 117 106 25 19
GLIPIZIDE 117 78 25 49
CLONIDINE HCL 111 86 27 40
CLOPIDOGREL 110 65 28 31
POTASSIUM CHLORIDE 103 75 29 14
TAMSULOSIN HCL 103 95 29 29
CITALOPRAM HBR 99 58 31 23
ATORVASTATIN CALCIUM 96 77 32 12
ALBUTEROL SULFATE 91 62 33 142
ALLOPURINOL 86 75 34 37
METOPROLOL SUCCINATE 86 64 34 13
CYCLOBENZAPRINE HCL 81 35 R 36 53
IBUPROFEN 79 44 37 65
AMANTADINE 78 49 38 411
METHOCARBAMOL 78 14 R 38 155
AZITHROMYCIN 70 49 40 33
ENALAPRIL MALEATE 70 49 40 41
ETODOLAC 69 58 42 160
DOXAZOSIN MESYLATE 69 56 42 98
EVISTA 66 59 44 128
PLAVIX 65 48 45 45
ACYCLOVIR 63 28 46 366
CARVEDILOL 61 43 47 25
BENAZEPRIL HCL 60 39 48 70
PRAVASTATIN SODIUM 60 43 48 11
MECLIZINE HCL 60 41 48 125
GLIPIZIDE ER 58 51 51 86
GLIMEPIRIDE 58 46 51 38
ATENOLOL 53 52 53 28
QUINAPRIL HCL 50 38 54 157
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 12, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.